```html

Keratoconjunctivitis and Photophobia

What is Keratoconjunctivitis Photophobia?

Keratoconjunctivitis refers to inflammation that affects both the cornea (the clear front surface of the eye) and the conjunctiva (the thin, vascular membrane that covers the white of the eye and lines the eyelids). When this inflammation is accompanied by photophobia—intolerance or pain caused by exposure to light—the condition is often described as keratoconjunctivitis with photophobia or simply “keratoconjunctivitis photophobia.”

The hallmark features are:

• Redness of the eye (hyperemia)
• Eye pain or a gritty sensation
• Blurred or decreased vision
• Increased tearing or discharge
• Marked sensitivity to light (photophobia)

Although the term combines two descriptors, the underlying problem is inflammation that can be triggered by a wide range of infectious, allergic, autoimmune, or environmental factors. Prompt recognition is important because some causes can threaten vision if left untreated.

Common Causes

The inflammation that produces keratoconjunctivitis and photophobia may arise from many different conditions. The most frequent culprits include:

• Viral conjunctivitis – Adenovirus, herpes simplex virus (HSV), and varicella‑zoster virus can infect the conjunctiva and cornea.
• Bacterial conjunctivitis – Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
• Allergic conjunctivitis – Seasonal or perennial allergies (e.g., pollen, dust mites, pet dander) cause eosinophilic inflammation.
• Dry‑eye disease (keratoconjunctivitis sicca) – Insufficient tear production or poor tear quality leads to ocular surface irritation.
• Contact‑lens‑related keratitis – Over‑wear, poor hygiene, or hypoxia can precipitate infection or sterile inflammation.
• Acanthamoeba keratitis – A rare but serious infection often linked to contaminated contact‑lens solutions.
• Autoimmune disorders – Sjögren’s syndrome, rheumatoid arthritis, and ocular cicatricial pemphigoid can cause chronic keratoconjunctivitis.
• UV or chemical exposure – Photokeratitis (“snow blindness”) and exposure to irritants such as chlorine, smoke, or cleaning agents.
• Medication‑induced toxicity – Topical eye drops containing preservatives (e.g., benzalkonium chloride) or systemic drugs like isotretinoin.
• Systemic infections – Measles, rubella, and COVID‑19 have ocular manifestations that may include keratoconjunctivitis.

Identifying the precise cause guides treatment, so a thorough history and eye examination are essential.

Associated Symptoms

Patients with keratoconjunctivitis and photophobia frequently report additional ocular or systemic signs, such as:

• Foreign‑body sensation – Feeling of something “in the eye.”
• Watery or mucoid discharge – May be clear (allergic) or purulent (bacterial).
• Blepharitis – Inflammation of the eyelid margins that can coexist.
• Reduced visual acuity – Blurring that improves when eyes are closed.
• Headache or facial pain – Often due to squinting or underlying sinus involvement.
• Systemic symptoms – Fever, malaise, or upper‑respiratory symptoms when infection is the trigger.
• Eye crusting upon waking – Common with bacterial or viral conjunctivitis.

When to See a Doctor

Most mild cases improve with basic home care, but you should seek professional evaluation promptly if you notice any of the following:

• Severe pain that does not improve with lubricating drops.
• Vision worsening or persistent blurring despite rest.
• Intense photophobia that forces you to keep the lights off.
• Yellow, green, or thick purulent discharge.
• Swelling of the eyelids or a feeling of the eye “sticking together.”
• History of recent eye trauma, surgery, or contact‑lens wear.
• Signs of a systemic infection (high fever, rash, joint pain).
• Any symptom that lasts longer than 48–72 hours without improvement.

Early assessment helps prevent complications such as corneal ulceration, scarring, or permanent loss of vision.

Diagnosis

Eye care professionals (optometrists or ophthalmologists) use a stepwise approach:

1. History taking – Duration, exposures (contact lenses, chemicals), allergies, systemic illnesses, medication use.
2. Visual acuity test – Determines the impact on sight.
3. Slit‑lamp examination – A microscope with a bright light that reveals corneal epithelial defects, stromal infiltrates, conjunctival injection, or foreign bodies.
4. Fluorescein staining – Drops of dye highlight corneal abrasions or ulcerations under cobalt blue light.
5. Culture or PCR – If bacterial, viral, or Acanthamoeba infection is suspected, specimens from the conjunctiva or cornea are collected for laboratory analysis.
6. Tear‑film analysis – Schirmer test or tear breakup time can assess dry‑eye disease.
7. Allergy testing – Skin prick or serum-specific IgE testing may be ordered for recurrent allergic keratoconjunctivitis.

In rare, chronic cases, imaging (e.g., anterior segment OCT) might be used to evaluate corneal thickness and scarring.

Treatment Options

Treatment is tailored to the underlying cause, severity, and patient factors. Below is a practical overview:

1. General supportive measures (home care)

• Apply preservative‑free lubricating eye drops several times daily to soothe dryness and dilute irritants.
• Use a cold compress for 5–10 minutes to reduce swelling and discomfort.
• Avoid bright lights; wear sunglasses with UV protection when outdoors.
• Practice strict hand hygiene and avoid touching the eyes.
• If you wear contact lenses, remove them immediately and discard disposable lenses or disinfect reusable lenses thoroughly.

2. Pharmacologic therapy

• Antibiotic eye drops or ointments – e.g., moxifloxacin, tobramycin, or erythromycin for bacterial infections (usually 5‑7 days).
• Antiviral medication – Topical ganciclovir for HSV keratitis or oral acyclovir/valacyclovir for herpetic disease.
• Antifungal drops – Natamycin for fungal keratitis (rare in temperate climates).
• Acanthamoeba treatment – Combination of polyhexamethylene biguanide (PHMB) and chlorhexidine for several weeks.
• Anti‑inflammatory agents – Short‑course topical corticosteroids (e.g., prednisolone acetate) for severe inflammation, prescribed under close supervision to avoid cataract or glaucoma.
• Antihistamine/mast‑cell stabilizer drops – Ketotifen, olopatadine, or azelastine for allergic keratoconjunctivitis.
• Cyclosporine A 0.05 % ophthalmic emulsion – For chronic dry‑eye–related keratoconjunctivitis.

3. Procedural interventions (when needed)

• Debridement of corneal epithelial defects.
• Therapeutic bandage contact lens to protect the cornea while it heals.
• Punctal plugs or intense moisturising regimens for refractory dry‑eye disease.
• In severe autoimmune disease, systemic immunosuppressants (e.g., azathioprine, mycophenolate) may be required under rheumatology/ophthalmology co‑management.

4. Follow‑up

Most acute infections improve within 1 week. However, a follow‑up visit within 48–72 hours is advised for bacterial keratitis, viral keratitis, or any case where vision is affected, to ensure the infection is responding and to prevent scarring.

Prevention Tips

Many triggers are modifiable. Incorporate these habits to lower the risk of developing keratoconjunctivitis with photophobia:

• Use proper contact‑lens hygiene – Wash hands, use fresh solution, replace lenses as recommended, avoid overnight wear unless approved.
• Protect eyes from UV and bright light – Wear 100 % UV‑blocking sunglasses during sunny days, on water, or at high altitudes.
• Maintain good indoor humidity – Use a humidifier in dry environments to reduce tear evaporation.
• Manage allergies early – Keep windows closed during high pollen counts, use HEPA filters, and start antihistamine eye drops at the first sign of itching.
• Avoid irritants – Smoke, chlorine pools, and harsh cleaning chemicals. Wear protective goggles when swimming or working with chemicals.
• Stay hydrated – Adequate fluid intake supports natural tear production.
• Regular eye examinations – Annual check‑ups, or more frequent if you have diabetes, autoimmune disease, or chronic dry eye.
• Promptly treat upper‑respiratory infections – Viral illnesses can spread to the eye; good hand hygiene reduces this risk.

Emergency Warning Signs

References

• Mayo Clinic. “Conjunctivitis (pink eye).” https://www.mayoclinic.org. Accessed June 2026.
• American Academy of Ophthalmology. “Keratitis.” https://www.aao.org. Updated 2025.
• Cleveland Clinic. “Dry Eye (Keratoconjunctivitis Sicca).” https://my.clevelandclinic.org. Accessed June 2026.
• Centers for Disease Control and Prevention. “Viral Conjunctivitis.” https://www.cdc.gov. 2024.
• National Eye Institute (NEI). “Acanthamoeba Keratitis.” https://www.nei.nih.gov. 2023.
• World Health Organization. “Photokeratitis (Snow Blindness).” https://www.who.int. 2022.
• Joo, C. K. et al. “Management of Infectious Keratitis.” *Ophthalmology*, 2021;128(5):702‑714. doi:10.1016/j.ophtha.2020.12.017.

```